Associated Skin Care Specialists | Minnesota Clinical Study Center
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Are at least 18 years and ≤60 years for males (≤70 years of age for females) at the time of informed consent.
Have severe or very severe AA, as determined by all of the following:
Male or nonpregnant, nonbreastfeeding female participants.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
546 participants in 6 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal